Combo immunotherapy for advanced melanoma: Two therapies may be better than one

Posted by on June 7, 2016 12:00 am
Categories: health

A new metastatic melanoma study suggests that a combination of two immunotherapies may be better than one. One treatment uses a patient’s own T cells modified in the lab to more powerfully recognize and attack tumors; the other treatment, a ‘checkpoint inhibitor,’ releases the brakes on the body’s natural immune system.

Leave a Reply

Your email address will not be published. Required fields are marked *